Kane Biotech Inc. (TSXV:KNE)
0.0300
0.00 (0.00%)
Jun 10, 2026, 3:44 PM EST
Kane Biotech Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.4 | 0.9 | 0.36 | 0.75 | 1.1 | 1.15 |
Cash & Short-Term Investments | 0.4 | 0.9 | 0.36 | 0.75 | 1.1 | 1.15 |
Cash Growth | -19.96% | 151.30% | -52.11% | -32.19% | -4.18% | 14.40% |
Accounts Receivable | 0.03 | 0.04 | 0.09 | 0.1 | 0.58 | 0.6 |
Other Receivables | - | - | - | - | 0.48 | 0.48 |
Total Trade Receivables | 0.03 | 0.04 | 0.09 | 0.1 | 1.06 | 1.07 |
Inventory | 0.48 | 0.5 | 0.38 | 0.25 | 0.76 | 0.52 |
Other Current Assets | 0.27 | 0.25 | 0.21 | 2.62 | 0.17 | 0.14 |
Total Current Assets | 1.17 | 1.69 | 1.03 | 3.72 | 3.1 | 2.88 |
Net Property, Plant & Equipment | 0.09 | 0.48 | 0.93 | 1.07 | 1.25 | 1.44 |
Other Intangible Assets | 0.55 | 0.57 | 0.54 | 0.73 | 0.83 | 0.83 |
Other Long-Term Assets | - | - | - | 0.16 | 0.44 | 0.99 |
Total Assets | 1.81 | 2.73 | 2.49 | 5.68 | 5.62 | 6.13 |
Accounts Payable | 1.21 | 1.08 | 1.65 | 1.61 | 1.85 | 2.06 |
Short-Term Debt | - | 1.25 | 0.34 | 6.97 | 4.17 | 2.38 |
Current Portion of Long-Term Debt | 1.28 | - | - | - | - | - |
Current Portion of Leases | - | 0.08 | 0.12 | 0.11 | 0.1 | 0.13 |
Unearned Revenue | - | - | - | 0.75 | 0.21 | 0.14 |
Other Current Liabilities | 0.1 | 0.1 | 0.3 | 1.46 | 0.01 | 0.01 |
Total Current Liabilities | 2.59 | 2.5 | 2.41 | 10.89 | 6.34 | 4.72 |
Long-Term Debt | 0.64 | 0.62 | 0.96 | 1.3 | 1.6 | 1.12 |
Long-Term Leases | - | 0.36 | 0.76 | 0.87 | 0.98 | 1.09 |
Other Long-Term Liabilities | - | - | - | 1.02 | 0.84 | 0.78 |
Total Long-Term Liabilities | 0.64 | 0.98 | 1.71 | 3.2 | 3.42 | 2.98 |
Total Liabilities | 3.23 | 3.48 | 4.12 | 14.09 | 9.76 | 7.7 |
Common Stock | 28 | 27.97 | 24.4 | 23.69 | 23.13 | 22.16 |
Additional Paid-in Capital | 8.44 | 8.42 | 8.38 | 7.89 | 7.44 | 7.17 |
Retained Earnings | -37.85 | -37.14 | -34.42 | -42.13 | -37.1 | -33.21 |
Total Common Shareholders' Equity | -1.42 | -0.75 | -1.63 | -10.56 | -6.52 | -3.89 |
Minority Interest | - | - | - | 2.15 | 2.38 | 2.32 |
Shareholders' Equity | -1.42 | -0.75 | -1.63 | -8.41 | -4.14 | -1.57 |
Total Liabilities & Equity | 1.81 | 2.73 | 2.49 | 5.68 | 5.62 | 6.13 |
Total Debt | 1.92 | 2.3 | 2.18 | 9.25 | 6.86 | 4.71 |
Net Cash (Debt) | -1.52 | -1.4 | -1.82 | -8.5 | -5.75 | -3.56 |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.07 | -0.05 | -0.03 |
Book Value | -1.42 | -0.75 | -1.63 | -10.56 | -6.52 | -3.89 |
Book Value Per Share | -0.01 | -0.00 | -0.01 | -0.08 | -0.05 | -0.03 |
Tangible Book Value | -1.97 | -1.31 | -2.17 | -11.29 | -7.35 | -4.71 |
Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.09 | -0.06 | -0.04 |